Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Prelude Therapeutics, Incorporated”

15 pharma patents match "Prelude Therapeutics, Incorporated" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 15
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 15 pharmaceutical patents matching "Prelude Therapeutics, Incorporated" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

15 results for “Prelude Therapeutics, Incorporated” · 30,257 patents in full index Clear search

  1. US 12414953

    Selective inhibitors of protein arginine methyltransferase 5 (PRMT5)

    Prelude Therapeutics, Incorporated · Granted Sep 16, 2025 · Expires Sep 11, 2045

    granted
  2. US 12129262

    CDK inhibitors and their use as pharmaceuticals

    Prelude Therapeutics, Incorporated · Granted Oct 29, 2024 · Expires Oct 24, 2044

    granted
  3. US 11939340

    CDK inhibitors and their use as pharmaceuticals

    Prelude Therapeutics, Incorporated · Granted Mar 26, 2024 · Expires Mar 21, 2044

    granted
  4. US 11702423

    BRM targeting compounds and associated methods of use

    Prelude Therapeutics, Incorporated · Granted Jul 18, 2023 · Expires Jul 13, 2043

    granted
  5. US 11685744

    CDK inhibitors and their use as pharmaceuticals

    Prelude Therapeutics, Incorporated · Granted Jun 27, 2023 · Expires Jun 22, 2043

    granted
  6. US 11673893

    CDK inhibitors and their use as pharmaceuticals

    Prelude Therapeutics, Incorporated · Granted Jun 13, 2023 · Expires Jun 8, 2043

    granted
  7. US 11622970

    BCL-2 inhibitors and their use as pharmaceuticals

    Prelude Therapeutics, Incorporated · Granted Apr 11, 2023 · Expires Apr 6, 2043

    granted
  8. US 11524962

    Substituted pyrrolo[2,3-d]pyrimidines as inhibitors of protein arginine methyl transferase 5 (PRMT5)

    Prelude Therapeutics, Incorporated · Granted Dec 13, 2022 · Expires Dec 8, 2042

    granted
  9. US 11254683

    Selective inhibitors of protein arginine methyltransferase 5 (PRMT5)

    Prelude Therapeutics, Incorporated · Granted Feb 22, 2022 · Expires Feb 17, 2042

    granted
  10. US 11220524

    Selective inhibitors of protein arginine methyltransferase 5 (PRMT5)

    Prelude Therapeutics, Incorporated · Granted Jan 11, 2022 · Expires Jan 6, 2042

    granted
  11. US 11214574

    Selective inhibitors of protein arginine methyltransferase 5 (PRMT5)

    Prelude Therapeutics, Incorporated · Granted Jan 4, 2022 · Expires Dec 30, 2041

    granted
  12. US 11208416

    Selective inhibitors of protein arginine methytransterase 5 (PRMT5)

    Prelude Therapeutics, Incorporated · Granted Dec 28, 2021 · Expires Dec 23, 2041

    granted
  13. US 11078205

    Selective inhibitors of protein arginine methlytransferase 5 (PRMT5)

    Prelude Therapeutics, Incorporated · Granted Aug 3, 2021 · Expires Jul 29, 2041

    granted
  14. US 10711007

    Selective inhibitors of protein arginine methyltransferase 5 (PRMT5)

    Prelude Therapeutics, Incorporated · Granted Jul 14, 2020 · Expires Jul 9, 2040

    granted
  15. US 10570140

    Selective inhibitors of protein arginine methyltransferase 5 (PRMT5)

    Prelude Therapeutics, Incorporated · Granted Feb 25, 2020 · Expires Feb 20, 2040

    granted